Nutrigenomics: A case for the common soil between cardiovascular disease and cancer

Genes and Nutrition

Volumn 3, Issue 1, 2008, Pages 19-24

  Iacoviello, Licia ^a   Santimone, Iolanda ^a   Latella, Maria Carmela ^a   Gaetano, Giovanni ^a   Donati, Maria Benedetta ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cancer; Cardiovascular disease; Nutrigenomics; Polyunsaturated fatty acids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FISH OIL; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ALLELE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BREAST CANCER; CANCER RISK; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUTRIGENOMICS; OBESITY; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 49749144154     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-008-0079-0     Document Type: Review

References (62)

1. Astorg P (2004) Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: A review of epidemiological and experimental evidence. Cancer Causes Control 15:367-386
2. Chajes V, Sattler W, Stranzl A, Kostner GM (1995) Influence of n-3 fatty acids of the growth of human breast cancer cells in vitro: Relationship to peroxides and vitamin-E. Breast Cancer Res Treat 34:199-212
3. Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N et al (2005) Nutrigenomics: The impact of biomics technology on nutrition research. Ann Nutr Metab 296:1858-1866
4. Donati MB (2003) Cancer and cardiovascular disease: Does a common soil exist? Pathophysiol Haemost Thromb 33(suppl 2):1
5. Dwyer JH, Allayee H, Dwyer KM et al (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350:29-37
6. Elliott R, Ong TJ (2002) Nutritional genomics. BMJ 324:1438-1442
7. Ferretti A, Nelson GJ, Scmidt PC, Kelley DS, Bartolini G, Flanagan VP (1997) Increased dietary arachidonic acid enhances the synthesis of vasoactive eicosanoids in humans. Lipids 32:435-439
8. Funk CD (2001) Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294:1871-1875
9. Furlong B, Henderson AH, Lewis MJ, Smith JA (1987) Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 90:687-692
10. Gago-Dominguez M, Castelao JE, Sun CL et al (2004) Marine n-3 fatty acid intake, gluthatione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore. Carcinogenesis 25:2143-2147
11. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cycling guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777
12. Ghosh D, Skinner MA, Laing WA (2007) Pharmacogenomics and nutrigenomics: synergies and differences. Eur J Clin Nutr 61:567-574
13. Gonzales MJ, Schemmel RA, Gray JI, Dugan L-Jr, Sheffield LG, Welsch CW (1991) Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: Relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis 12:1231-1235
14. Gonzalez MJ, Schemmel RA, Dugan L Jr, Gray JI, Welsch CW (1993) Dietary fish oil inhibits human breast carcinoma growth: A function of increased lipid peroxidation. Lipids 28:827-832
15. Goode GK, Garcia S, Heagerty AM (1997) Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients. Circulation 96:2802-2807
16. Grooskopf I, Barouk N, Lee SJ, Kamari Y, Harats D, Rubin EM, Pennacchio LA, Cooper AD (2005) APOA5 deficiency results in marked hypetriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 25:2573-2579
17. Hedelin M, Chang ET, Wilklund F, Bellocco R et al (2006) Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 120:398-405
18. Hibi K, Ishigami T, Tamura K, Mizushima S et al (1998) Endothelial nitric oxide synthase gene polimorphism and acute myocardial infarction. Hypertension 32:521-526
19. 298 →Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520
20. Jang Y, Kim JY, Kim OY, Lee JE, Cho H, Ordovas JM, Lee JH (2004) The -1131T>C polymorphism in the APOA5 gene is associated with post-prandial hypertricylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in non-obese Korean men. Am J Clin Nutr 80:832-840
21. Juo SH, Wyszynski DF, Beaty TH, Bailey-Wilson JE (1999) Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: A meta-analysis. Am J Med Genet 82:235-241
22. Kelley DS, Taylor PC, Nelson GJ, Mackey BE (1998) Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids 33:125-130
23. Kihara M, Umemura S, Kadota T, Yabana M, Tamura K, Nyui N, Ogawa N, Murakami K, Fukamizu A, Ishii M (1997) The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene-knockout mice. Lab Invest 76:285-294
24. Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu XH, Levine AC (2000) Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 56:671-676
25. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H (1996) Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 94:266-272
26. Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA (1992) Comparison of the plasma levels of apolipoproteins B and A-I, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69:1015-1021
27. Lai C-Q, Corella D, Demissie S et al (2006) Dietary Intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size. Circulation 113:2062-2070
28. Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, Corella D, Ordovas JM (2004) Influnce of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham heart study. J Lipid Res 45:2096-2105
29. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 79:935-945
30. Lee LM, Pan CC, Cheng CJ, Chi CW, Liu TY (2001) Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Res 21:1291-1294
31. Leeson CP et al (2002) Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Cir Res 90:1153-1158
32. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241
33. Mahmud S, Franco E, Aprikian A (2004) Prostate cancer and use of nonsteroidal anti-inflammatory drugs: Systematic review and meta-analysis. Br J Cancer 90:93-99
34. Martin S, Nicaud V, Humphries SE, Talmud PJ, on behalf of the EARS group (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to response to both fat and glucose tolerance challenges. Biochim Biophis Acta 1637:217-225
35. Mata P, Lopez-Miranda J, Pocovi M et al (1998) Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 137:367-376
36. Matsunaga A, Sasaki J, Han H et al (1999) Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency. Arterioscler Thromb Vasc Biol 19:348-355
37. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J (2005) APOA5 accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280:21553-21560
38. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. New Engl J Med 329:2002-2012
39. Moncada S (1992) The L-arginine-nitric oxide pathway. Acta Physiol Scand 145:201-227
40. Nestel PJ (2000) Fish oil and cardiovascular disease: Lipids and arterial function. Am J Clin Nutr 71:228-231
41. Ordovas JM, Corella D, Cupples LA et al (2002) Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham study. Am J Clin Nutr 75:38-46
42. Ordovas JM (2006) Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 83(suppl 2):443S-446S
43. Pennacchio LA, Oliver M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC (2002) Two independent APOA5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11:3031-3038
44. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III (1995) Nitric oxide activity in the human coronary circulation. J Clin Invest 95:1747-1755
45. Radomski MW, Palmer RMJ, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endhotelium. Lancet 2:1057-1058
46. Rensen PC, van Dijk KW, Havekes LM (2005) APOA5: Low concentration, high impact. Arterioscler Thromb Vasc Biol 25:2445-2447
47. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
48. Sampath H, Ntambi JM (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25:317-340
49. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 237:1171-1176
50. Sessler AM, Ntambi JM (1998) Polyunsaturated fatty acid regulation of gene expression. J Nutr 128:923-6
51. Shaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk Kw (2004) APOA5 reduces plasma triglycerides by inhibiting VLDL-TG production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279:27941-27947
52. Shibuki K, Okada D (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349:326-328
53. Simopoulos A, Cleland L (2003) Omega-6/omega-3 essential fatty acid ratio: The scientific evidence. Basel: Karger AG
54. Stover PL (2006) Influence of human genetic variations on nutritional requirements. Am J Clin Nutr 83:436S-442S
55. Terry PD, Rohan TE, Wolk A (2003) Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: A review of the epidemiologic evidence. Am J Clin Nutr 77:532-543
56. Terry PD, Terry JB, Rohan TE (2004) Long chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: Recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr 134:S3412-S3420
57. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000
58. Weinberg RB, Cook VR, Beckstead JA, Martin DD, Gallagher JW, Shelness GS, Ryan RO (2003) Structure and interfacial properties of human APOA5. J Biol Chem 278:34438-34444
59. Wilson PW, Abbott RD, Castelli WP (1988) High density lipoprotein cholesterol and mortality. The Framingham heart study. Ateriosclerosis 8:737-741
60. Yao S-K, Ober CJ, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, Willerson JT (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endhotelium-injured arteries. Circulation 86:1302-1309
61. Yasue H, Yoshimura M, Sugiyama S, Sumida H, Okumura K, Ogawa H, Kugiyama K, Ogawa Y, Nakao K (1995) Association of a point mutation of the endothelial cell nitric oxide synthase (eNOS) gene with coronary spasm. Circulation 92:I-363. Abstract
62. Ye SQ, Kwiterovich PO Jr (2000) Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 72:1275S-1284S